NextCure Inc
NASDAQ:NXTC
Intrinsic Value
The intrinsic value of one NXTC stock under the Base Case scenario is 13.17 USD. Compared to the current market price of 4.94 USD, NextCure Inc is Undervalued by 63%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
NextCure Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
NextCure Inc
Balance Sheet Decomposition
NextCure Inc
Current Assets | 40m |
Cash & Short-Term Investments | 35.3m |
Other Current Assets | 4.7m |
Non-Current Assets | 7.7m |
PP&E | 7.1m |
Other Non-Current Assets | 555k |
Free Cash Flow Analysis
NextCure Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
NextCure Inc
Revenue
|
0
USD
|
Operating Expenses
|
-63.2m
USD
|
Operating Income
|
-63.2m
USD
|
Other Expenses
|
2.3m
USD
|
Net Income
|
-60.9m
USD
|
NXTC Profitability Score
Profitability Due Diligence
NextCure Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
NextCure Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
NXTC Solvency Score
Solvency Due Diligence
NextCure Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Score
NextCure Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NXTC Price Targets Summary
NextCure Inc
According to Wall Street analysts, the average 1-year price target for NXTC is 17.85 USD with a low forecast of 15.15 USD and a high forecast of 21 USD.
Dividends
Current shareholder yield for NXTC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one NXTC stock under the Base Case scenario is 13.17 USD.
Compared to the current market price of 4.94 USD, NextCure Inc is Undervalued by 63%.